Penicillin Allergy Delabeling Program: an exploratory economic evaluation in the Australian context.
Natasha K Brusco, Susan Bury, Kyra YL Chua, Sara Vogrin, Natasha E Holmes, Jason A Trubiano
Intern Med J | Published : 2021
BACKGROUND: Internationally, clinical and economic advantages of low-risk penicillin delabeling have been explored, supporting changes to healthcare delivery systems where penicillin delabeling is embedded into inpatient usual care. AIM: To determine if economic advantages of low-risk inpatient penicillin delabeling, described in the international literature, are realised in the Australian context. METHODS: This explorative economic evaluation had prospective patient data collection between January and August 2019, across two Australian health services. Part-1: Determine the cost per effectively delabeled patient for Penicillin Allergy Delabeling Program inpatients (PADP cohort) compared to ..View full abstract